Containing Or Obtained From Labiatae (e.g., Oregano, Marjoram, Etc.) Patents (Class 424/745)
  • Publication number: 20120231097
    Abstract: This invention provides a traditional Chinese medicine composition consisting of the extract of no more than five crude drugs, wherein crude drugs include licorice and also include Radix Scutellariae or Rhizoma Polygoni Cuspidati. In addition, this invention also provides the preparations, treatment methods, treatment applications and preparation methods of the above traditional Chinese medicine compositions.
    Type: Application
    Filed: November 25, 2010
    Publication date: September 13, 2012
    Inventors: James Zhou, Dong Chen
  • Publication number: 20120230926
    Abstract: A method of cosmetic care comprising activating capsase-14 expression in skin deficient in caspase-14 expression by applying, on at least one skin zone in need thereof, an effective amount of a plant extract selected from the group consisting of litchi, glasswort, peach, soja seed, sweet basil, cucumber, chanterelle, leek, kiwi fruit, rhubarb, grapefruit, wheat, raspberry, plum, and mixtures thereof, to activate caspase-14 expression in said skin.
    Type: Application
    Filed: March 8, 2011
    Publication date: September 13, 2012
    Inventors: Hugo A. Corstjens, Lieve Declercq, Gerry Eyckmans, Luc F.J. Van Overloop
  • Publication number: 20120219647
    Abstract: The present invention relates to compositions comprising an edible oil having improved oxidative stability and methods for manufacturing such compositions. The composition contains an active fraction of a green tea extract, partial glycerides in an amount of at least 2% and an edible oil. The partial glycerides may contain mono- and/or diglycerides and the edible oil may be a polyunsaturated oil, e.g. a fish oil.
    Type: Application
    Filed: July 20, 2010
    Publication date: August 30, 2012
    Inventors: Harald Breivik, Vidar Moen, Tanja Vojnovic
  • Patent number: 8252345
    Abstract: The inventive subject matter relates to methods for modulating an eicosanoid metabolic process in cells of an animal in need thereof, which comprises administering to the animal an amount of the inventive compositions effective for regulating the activity of an eicosanoid oxygenase. In particular, the inventive subject matter relates to methods for modulating arachidonic acid metabolism by administering an amount of the inventive compositions effective for regulating the activity of lipoxygenases and cyclooxygenases.
    Type: Grant
    Filed: December 29, 2008
    Date of Patent: August 28, 2012
    Assignee: New Chapter Inc.
    Inventors: Thomas Newmark, Paul Schulick, Robert Newman, Bharat Aggarwal
  • Publication number: 20120213869
    Abstract: A pain relieving composition that includes an anesthetic in the range of 0.5%-7.0% by weight (“w/w”), an anti-inflammatory agent in the range of 1.0%-11.0% w/w, a moisturizing agent in the range of 0.5%-12.0% w/w, a humescent in the range of 0.5%-13.0% w/w, a penetration enhancing agent in the range of 0.5%-7.0%, and a carrier solvent in the range of 40.0%-97.0% w/w to be used before and/or after procedures which cause damage to human skin.
    Type: Application
    Filed: February 23, 2011
    Publication date: August 23, 2012
    Applicant: MISS SMARTY PANTS ENTERPRISES, INC.
    Inventor: Edna Ma
  • Publication number: 20120207862
    Abstract: Described are compositions and agents for blocking serum and other aging factors, especially arNOX in serum, skin or other body fluid or tissue and/or on the cell surface, and methods for using the same. More particularly, the invention relates to agents comprising any one of several naturally-occurring arNOX inhibitors capable of reducing occurrence or severity of or treating disorders and complications of disorders resulting from cell damage caused by aging-related isoforms of NADH oxidase (arNOX). In one exemplary embodiment, nutraceutical, cosmeceutical or pharmaceutical compositions comprise at least one naturally occurring arNOX inhibitor or inhibitor source. Such naturally occurring inhibitors also are capable of augmenting the anti-arNOX effect of other naturally occurring arNOX inhibitory agents.
    Type: Application
    Filed: September 1, 2011
    Publication date: August 16, 2012
    Inventors: D. James Morré, Dorothy M. Morré, Thomas Shelton
  • Publication number: 20120201902
    Abstract: The present invention relates to a preservative or antimicrobial compositions which comprise low concentrations of botanical extracts, in synergistic combinations with alkanediols in a solvent system, optionally with fruit acids. Additionally, the present invention relates to a preservative or antimicrobial compositions which comprise a silver compound, an essential oil or individual constituent, one or more zinc salts, and one or more alkanediol. The compositions of the invention may be used in personal care products including wound care products or in veterinary use. Preferably, the compositions of the invention have little or no human-detectable fragrance.
    Type: Application
    Filed: December 22, 2011
    Publication date: August 9, 2012
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: Shanta M. Modak, Nayana Baiju, Lauserpina A. Caraos, Hari Krishnan Ramachandran
  • Publication number: 20120201912
    Abstract: Medicaments and therapeutic compositions comprise a composition (1) comprising at least one polyunsaturated fatty acid, at least one pharmaceutically acceptable derivative of a polyunsaturated fatty acid or mixtures thereof and a composition (2) comprising Red Yeast Rice extract comprising about 0.8 wt. % or more monacolin K. One source of component (1) is fish oil. The compositions are useful for lowering cholesterol and/or triglyceride levels in a subject.
    Type: Application
    Filed: April 10, 2012
    Publication date: August 9, 2012
    Inventor: Joar A. Opheim
  • Publication number: 20120195987
    Abstract: Medicaments and therapeutic compositions comprise a composition (1) comprising (A) EPA, pharmaceutically acceptable derivatives of EPA or mixtures thereof, and, optionally, (B) DHA, pharmaceutically acceptable derivatives of DHA or mixtures thereof, wherein the weight ratio of A:B is about 7.5:1 or more, and a composition (2) comprising monacolin K, a source of monacolin K or mixtures thereof. One source of component (1) is fish oil. One source of monacolin K is Red Yeast Rice extract. The compositions are useful for lowering cholesterol and/or triglyceride levels in a subject.
    Type: Application
    Filed: April 10, 2012
    Publication date: August 2, 2012
    Inventor: Joar A. Opheim
  • Publication number: 20120189723
    Abstract: A herbal composition comprising supercritical fluid extracts/oils of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E is effective in the treatment of symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD).
    Type: Application
    Filed: December 29, 2011
    Publication date: July 26, 2012
    Applicant: NISARGA BIOTECH PVT.LTD.
    Inventors: Girish Sudhakar SOMAN, Shrikrishna Govind Phadke
  • Patent number: 8226987
    Abstract: An herbal preparation comprised of sage, thyme and cumin is found to relieve the symptoms of inflammation and smooth muscle contraction. The preparation preferably comprises sage, thyme and cumin in the proportions 0.50, 0.43 and 0.07 respectively. The symptoms of menstrual cramps and asthma are relieved by administration of the preparation.
    Type: Grant
    Filed: February 22, 2005
    Date of Patent: July 24, 2012
    Inventor: George K. Zoorob
  • Publication number: 20120183635
    Abstract: Rosemary extracts are used in the treatment of disorders connected to reduced neurotransmission, as well as dietary and pharmaceutical compositions containing these rosemary extracts.
    Type: Application
    Filed: March 29, 2012
    Publication date: July 19, 2012
    Applicant: DSM IP ASSETS B.V.
    Inventors: Antoine De Saizieu, Ann Fowler, Regina Goralczyk, Claus Kilpert, Goede Schueler
  • Publication number: 20120183634
    Abstract: A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
    Type: Application
    Filed: March 26, 2012
    Publication date: July 19, 2012
    Applicant: METAPROTEOMICS, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Gary K. Darland, Robert Lerman, Daniel O. Lukaczer, DeAnn J. Liska, Terrence Howell
  • Publication number: 20120177756
    Abstract: A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
    Type: Application
    Filed: March 26, 2012
    Publication date: July 12, 2012
    Applicant: METAPROTEOMICS, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Gary K. Darland, Robert Lerman, Daniel O. Lukaczer, DeAnn J. Liska, Terrence Howell
  • Publication number: 20120171311
    Abstract: Medicaments and therapeutic compositions comprise (1) a mixture comprising (A) EPA, pharmaceutically acceptable derivatives of EPA or mixtures thereof, and, optionally, (B) DHA, pharmaceutically acceptable derivatives of DHA or mixtures thereof, wherein the weight ratio of A:B is about 7.5:1 or more, and (2) monacolin K, a source of monacolin K or mixtures thereof. One source of component (1) is fish oil. One source of monacolin K is Red Yeast Rice extract. The compositions are useful for lowering cholesterol and/or triglyceride levels in a subject.
    Type: Application
    Filed: March 14, 2012
    Publication date: July 5, 2012
    Inventor: Joar A. Opheim
  • Publication number: 20120171133
    Abstract: Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents that modulate dynein expression in the skin. Also provided are methods for screening for substances which modulate dynein expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin.
    Type: Application
    Filed: November 29, 2011
    Publication date: July 5, 2012
    Applicant: AVON PRODUCTS, INC.
    Inventors: Qian ZHENG, John W. LYGA, Russell J. WYBORSKI
  • Publication number: 20120171294
    Abstract: The present invention relates to starch foam microparticles having a porous structure, and which typically have a diameter of less than or equal to about 50 microns. The present invention also relates to novel uses for the starch foam microparticles in beekeeping and in the pharmaceutical, plastics and fragrance industries.
    Type: Application
    Filed: March 15, 2012
    Publication date: July 5, 2012
    Applicant: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Gregory M. Glenn, Artur P. Klamczynski
  • Publication number: 20120156316
    Abstract: There are disclosed non-phytotoxic biocompatible compositions comprising tea tree oil (TTO), as well as their use and methods for their production. Other embodiments are also disclosed.
    Type: Application
    Filed: November 17, 2011
    Publication date: June 21, 2012
    Applicant: BIOMOR ISRAEL LTD.
    Inventors: Gregory PIPKO, Moshe Reuveni, Dani Neifeld
  • Patent number: 8202512
    Abstract: A combination of chemical agents reduces reductive stress by limiting the accumulation of high-energy electrons potentially available to the electron transport chain. A method of metabolic uncoupling therapy comprises: analyzing a specific physiologic process involving reductive stress; identifying a plurality of MUT agents that modulate metabolic pathways by influencing electron flux; and formulating a combination of MUT agents that limits the accumulation of high-energy electrons potentially available to the electron transport chain.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: June 19, 2012
    Inventor: Edward Larry McCleary
  • Patent number: 8202550
    Abstract: Pharmaceutical compositions are for administration to the nasal tract. In particular, dry powder compositions are cellulose, and in particular hydroxypropylmethylcellulose (HPMC), and one or more therapeutic agents. It has been shown that administration of HPMC to the nasal cavity is capable of enhancing natural mucus. These powders, and the gel that forms when they are administered to the nasal tract, have now surprisingly been found to be a very effective way of intranasally administering therapeutic agents, and in particular, herbal or homeopathic agents.
    Type: Grant
    Filed: October 10, 2005
    Date of Patent: June 19, 2012
    Assignee: Nasaleze PPM Limited
    Inventors: Michael James, Peter Josling
  • Publication number: 20120148685
    Abstract: The present invention relates to compositions comprising (i) an activator of transport of fatty acids into the mitochondria; (ii) an activator of fatty acid oxidation; and (iii) an inhibitor of fatty acid biosynthesis, and methods for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome, dyslipidemias, obesity, and/or cardiovascular disorders in a subject.
    Type: Application
    Filed: June 10, 2010
    Publication date: June 14, 2012
    Applicant: Engergy4Life AG
    Inventor: Markus Rohner
  • Publication number: 20120148651
    Abstract: According to one embodiment, a coagulant comprising calcium nitrate and an antimicrobial agent is disclosed. The coagulant may be used in the molding process to releasably bond the substrate material to the mold and to bond to the antimicrobial to the substrate material.
    Type: Application
    Filed: December 10, 2010
    Publication date: June 14, 2012
    Applicant: MEDLINE INDUSTRIES INC.
    Inventors: Samuel T. Amdur, Min Yao
  • Publication number: 20120141616
    Abstract: A composition for increasing the bioavailability of oregano essential oil in humans and animals comprising mixing a first emulsifier and a second emulsifier in a ratio ranging from about 1:1 to about 3:1 with a consumable oil wherein the first emulsifier is polyoxyethylene sorbitan monooleate and the second emulsifier is tocopheryl polyethylene glycol succinate. Adding to that a second mixture of oregano essential oil and the first emulsifier in a ratio of 1:1.
    Type: Application
    Filed: December 1, 2010
    Publication date: June 7, 2012
    Inventors: Bhiku Patel, Robert L. Knechtel
  • Publication number: 20120135094
    Abstract: The present invention relates to bioactivity-guided isolation and identification of bioactive compounds from oregano and mint plants, in particular, rosmarinic acid, oleanolic acid and ursolic acid, and use of these compounds or combinations thereof as anti-inflammatory agents for the treatment of conditions related to pain and inflammation and/or as ingredients of dietary supplements. The invention also relates to optimization of the methods for qualitative and quantitative analysis of the bioactive compounds in oregano and mint plants. In particular, this invention introduces an LC/MS (SIM mode) method to achieve co-quantitation of the three organic acids using a unique tandem column system. In addition, the invention also relates to the methods for recovering various water-soluble polyphenols and triterpenes from aromatic plants.
    Type: Application
    Filed: May 14, 2010
    Publication date: May 31, 2012
    Applicant: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: James E. Simon, Diandian Shen, Hector Rodolfo Juliani, Qingli Wu
  • Publication number: 20120121739
    Abstract: The present invention is directed to bioactive botanical cosmetic compositions derived from membrane and cell serum fractions of plant cell juice. The present invention also relates to the methods for preparing these bioactive botanical cosmetic compositions and the uses of these compositions in various cosmetic formulations and as topical skin cosmetic applications.
    Type: Application
    Filed: January 22, 2012
    Publication date: May 17, 2012
    Applicant: AKZO NOBEL SURFACE CHEMISTRY LLC
    Inventor: Michael KOGANOV
  • Publication number: 20120121736
    Abstract: The present invention relates to a herbal composition for treating gastric ulcer, a method for preparing said herbal composition.
    Type: Application
    Filed: April 15, 2010
    Publication date: May 17, 2012
    Inventor: Yu Bao Zhang
  • Publication number: 20120121738
    Abstract: The present invention is directed to bioactive botanical cosmetic compositions derived from membrane and cell serum fractions of plant cell juice. The present invention also relates to the methods for preparing these bioactive botanical cosmetic compositions and the uses of these compositions in various cosmetic formulations and as topical skin cosmetic applications.
    Type: Application
    Filed: January 22, 2012
    Publication date: May 17, 2012
    Applicant: AKZO NOBEL SURFACE CHEMISTRY LLC
    Inventor: Michael KOGANOV
  • Patent number: 8173182
    Abstract: Antimicrobial compositions based on a combination or blend of plant essential oils is of enhanced antimicrobial effectiveness; by adding to the combination of at least two plant essential oils, and preferably adds a small but antimicrobial enhancing effective amount of an enhancer selected from the group consisting of polyionic organic enhancers and polyionic inorganic enhancers. One preferred blended oil composition is a mixture of plant essential oils wherein at least one of the oils is oregano oil. The oil blend is used as a major component in the finished product anti-microbial.
    Type: Grant
    Filed: October 27, 2011
    Date of Patent: May 8, 2012
    Inventor: Ronald R. Van Beek
  • Publication number: 20120107428
    Abstract: Provided herein are essential oils and synthetic compounds, and combinations thereof, as repellent compositions for repelling insects, such as vespid social wasps (Vespidae), including yellowjackets, paper wasps, and hornets. Controlled release devices comprising these repellent compositions are also provided.
    Type: Application
    Filed: August 9, 2011
    Publication date: May 3, 2012
    Applicant: Sterling International Inc.
    Inventors: Rodney G. Schneidmiller, Qing-He Zhang, Doreen R. Hoover
  • Publication number: 20120093888
    Abstract: A formulation to treat rheumatic disorders and related infections is provided. The formulation is a micro-emulsion including at one or more of an active ingredients. The active ingredient includes one or more of an essential oil mixed with an aqueous phase along with one or more of a surfactant and one or more of a co-surfactant. The co-surfactant is medicated by an extract of one or more of an herb.
    Type: Application
    Filed: June 4, 2010
    Publication date: April 19, 2012
    Inventors: Manu Chaudhary, Vijay Naithani
  • Patent number: 8158166
    Abstract: Antimicrobial compositions based on a combination or blend of plant essential oils is of enhanced antimicrobial effectiveness; by adding to the combination of at least two plant essential oils, and preferably adds a small but antimicrobial enhancing effective amount of an enhancer selected from the group consisting of polyionic organic enhancers and polyionic inorganic enhancers. One preferred blended oil composition is a mixture of plant essential oils wherein at least one of the oils is oregano oil. The oil blend is used as a major component in the finished product anti-microbial.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: April 17, 2012
    Inventor: Ronald R. Van Beek
  • Publication number: 20120087987
    Abstract: The present disclosure relates to the combined use of two pesticides. A first pesticide composition provides an initial contact kill, and may form a barrier when applied to greasy surfaces. A second pesticide composition provides residual pesticidal activity on the surface. Methods of making and using the pesticide compositions are also provided.
    Type: Application
    Filed: October 12, 2011
    Publication date: April 12, 2012
    Applicant: ECOLAB USA INC.
    Inventors: Victor F. Man, S. John Barcay, Darren M. Jahnke, Yvonne M. Killeen
  • Publication number: 20120087871
    Abstract: Methods for killing insects and a nest are disclosed. The methods may be used to disrupt a colony of nestdwelling insects. The insects may include wasps, hornets, and yellowjackets.
    Type: Application
    Filed: September 30, 2011
    Publication date: April 12, 2012
    Applicant: STERLING INTERNATIONAL INC.
    Inventors: Rodney G. Schneidmiller, Qing-He Zhang, Guiji Zhou, Doreen R. Hoover
  • Publication number: 20120082739
    Abstract: Disclosed herein are compositions and methods for the treatment and management of pain in a subject, comprising topically or orally administering a therapeutically effective amount of a composition comprising herbal extracts and compound mixtures to a subject.
    Type: Application
    Filed: February 28, 2011
    Publication date: April 5, 2012
    Inventor: Reza Ghorbani
  • Patent number: 8147877
    Abstract: Disinfecting compositions having tuberculocidal and fungicidal efficacies for disinfecting and sanitizing inanimate surfaces is provided. The disinfecting compositions contain thyme oil or thyme oil and origanum oil, a salt of a transition metal, a biobased surfactant and water. This improved disinfecting composition is botanical, environmentally sustainable, non-toxic, mildly scented and highly stable.
    Type: Grant
    Filed: June 1, 2006
    Date of Patent: April 3, 2012
    Assignee: OhSo Clean, Inc.
    Inventors: S. Samuel DeAth, Larry Weiss
  • Publication number: 20120076742
    Abstract: A topical drug delivery system for use as a self-medication delivery system, formed as a multi-functional hygroscopic solution comprising a non-hygroscopic first chemical penetration enhancer, a hygroscopic second chemical penetration enhancer and an anti-oxidizing dispersant mixable in solution with the first and second chemical penetration enhancers and an active pharmaceutical ingredient, said dispersant being in a weight percent of the solution of between 3% and 10% and being suitable for providing multiple secondary therapeutic effects by interaction with the active pharmaceutical ingredient to ensure substantial homogenous distribution of the selected active pharmaceutical ingredient in the solution during delivery of the solution to all areas of the mammalian tissue location and by further reducing the water activity level of the solution.
    Type: Application
    Filed: April 21, 2011
    Publication date: March 29, 2012
    Inventors: D. Howard Phillips, Steven Keough
  • Publication number: 20120070479
    Abstract: The present invention generally relates to a wet wipe or sheet that is suitable for contacting the skin and removing mucus from the skin. More specifically, the present invention relates to a wet wipe having an aqueous saline component suitable for dissolving and removing mucus in combination with the fabric matrix of the wet wipe. Typically, the fabric matrix of the wet wipe has a capacity of about 125 grams of solution per square meter, and it is impregnated with the aqueous saline solution to a level at or below approximately 80% of the absorbent capacity of the matrix.
    Type: Application
    Filed: November 30, 2011
    Publication date: March 22, 2012
    Applicant: LITTLE BUSY BODIES, INC.
    Inventors: Mindee K. Doney, Julienne M. Pickens
  • Publication number: 20120064021
    Abstract: The invention relates to a cosmetic composition comprising at least one extract from the orchid Dendrobium chrysotoxum as an active agent and at least one cosmetically acceptable excipient. The invention relates to the use in a cosmetic composition of an extract from the orchid Dendrobium chrysotoxum as an active agent for preventing or delaying the appearance of the signs of skin ageing or for slowing or attenuating the effects thereof, or else also for promoting cell or tissue longevity. The invention in particular relates to an orchid extract inhibiting the expression and/or the activity of the mitochondrial protein Smac/DIABLO.
    Type: Application
    Filed: September 13, 2011
    Publication date: March 15, 2012
    Applicant: LVMH RECHERCHE
    Inventors: Virginie LEPLANQUAIS, Patrice ANDRE, Virginie PECHER
  • Publication number: 20120039965
    Abstract: Antimicrobial compositions based on a combination or blend of plant essential oils is of enhanced antimicrobial effectiveness; by adding to the combination of at least two plant essential oils, and preferably adds a small but antimicrobial enhancing effective amount of an enhancer selected from the group consisting of polyionic organic enhancers and polyionic inorganic enhancers. One preferred blended oil composition is a mixture of plant essential oils wherein at least one of the oils is oregano oil. The oil blend is used as a major component in the finished product anti-microbial.
    Type: Application
    Filed: October 27, 2011
    Publication date: February 16, 2012
    Inventor: RONALD R. VAN BEEK
  • Patent number: 8114446
    Abstract: The inventive subject matter relates to methods for modulating an eicosanoid metabolic process in cells of an animal in need thereof, which comprises administering to the animal an amount of the inventive compositions effective for regulating the activity of an eicosanoid oxygenase. In particular, the inventive subject matter relates to methods for modulating arachadonic acid metabolism by administering an amount of the inventive compositions effective for regulating the activity of lipoxygenases and cyclooxygenases.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: February 14, 2012
    Assignees: New Chapter Inc., Board Of Regents Of The University Of Texas System
    Inventors: Thomas Newmark, Paul Schulick, Robert Newman, Bharat Aggarwal
  • Patent number: 8110229
    Abstract: Disclosed herein is a herbal composition comprising supercritical fluid extracts/oils of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E in an effective amounts useful in the treatment of symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD).
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: February 7, 2012
    Assignee: Nisarga Biotech Pvt Ltd.
    Inventors: Girish Sudhakar Soman, Shrikrishna Govind Phadke
  • Patent number: 8110228
    Abstract: A method of using an herbal extract of the a mixture of: Herba Scutellaria barbata, Radix Sophora subprostratae, Radix Anemarrhena, Semen Glycine sojae, Radix Glycyrrhiza, Rhizoma Rhei, Fructus Tritici levis, Radix Astragali, Radix Rehmania, Fructus Ligustri lucidi, Semen Zyziphi spinosa, Plumula Nelumbinis, Poria cocas, Rhizoma Alismatis, Cortex Moutan radicis, Fructus Corni, Radix Achyranthis, Concha Ostrea, Radix Aspargi, Radix Pueraria, Radix Atractylodis macrocephala and Herba Epimedium, for the treatment of hot flashes associated with menopause is disclosed herein.
    Type: Grant
    Filed: October 28, 2008
    Date of Patent: February 7, 2012
    Assignee: Bionovo, Inc.
    Inventor: Isaac Cohen
  • Publication number: 20120027787
    Abstract: A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.
    Type: Application
    Filed: September 13, 2011
    Publication date: February 2, 2012
    Applicant: U.S. Nutraceuticals, LLC d/b/a Valensa International
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
  • Publication number: 20120021076
    Abstract: The present invention provides a method of toning the face comprising the steps of (a) dissolving in water a toner concentrate in the form of a solid comprising (i) citric acid; (ii) sodium bicarbonate; (iii) one or more essential oils; to provide a toner, and (b) applying the toner to the face.
    Type: Application
    Filed: June 2, 2009
    Publication date: January 26, 2012
    Inventors: Mark Constantine, Margaret Joan Constantine, Helen Elizabeth Ambrosen
  • Publication number: 20120014934
    Abstract: A natural color is concentrated to intensify color range and to provide useful amounts of one or more of anti-oxidant, nutritional, and anti-inflammatory compounds derived from one or more pigment sources. In a preferred embodiment, the pigment source is a fruit, a vegetable, a legume, a spice, algae, or a combination thereof.
    Type: Application
    Filed: July 13, 2011
    Publication date: January 19, 2012
    Inventors: Paul Altaffer, Jeffrey M. Wuagneux, Pi-Yu Hsu
  • Publication number: 20120015059
    Abstract: Provided is a composition for preventing or treating insomnia. The composition includes, as an active ingredient, extract of Phlomis umbrosa Turcz. or a combination thereof with extract of Polygala tenuifolia Willd. Particularly, the combination of extract of Phlomis umbrosa Turcz. with extract of Polygala tenuifolia Willd. enables recovery of the sleep of patients suffering from insomnia nearly to that of normal persons. The composition for treating insomnia uses active ingredients that have been used as Chinese traditional medicines, and thus is safe to the human body.
    Type: Application
    Filed: March 18, 2010
    Publication date: January 19, 2012
    Applicant: Natural Endotech Co., Ltd
    Inventors: Jae-Soo Kim, Bo-Yeon Kwak
  • Publication number: 20120009283
    Abstract: Combinations of vasoactive substances which are useful in the treatment of sexual dysfunctions associated with poor local blood supply and/or insufficient lubrication are provided. The vasoactive compounds are esculoside, visnadine, forskolin or extracts thereof, purified lipophilic extracts from plants of the genus Ipomea, esters of ximenynic acid, icarin or icarin derivatives, amentoflavone, and Gingko biloba dimeric flavones. The combination of these vasoactive substances is incorporated in gels and lotions designed to be applied to the genital organs. These formulations are useful in inducing erection of the male and female sex organs and enhancing orgasm and sexual performance. The formulations are particularly useful in the treatment of female sexual dysfunctions.
    Type: Application
    Filed: September 22, 2011
    Publication date: January 12, 2012
    Applicant: INDENA S.P.A.
    Inventor: Ezio BOMBARDELLI
  • Publication number: 20110305780
    Abstract: The invention comprises a composition for the reduction of snoring, a packaging therefor and a method for the manufacture thereof. The composition can be applied in the pharynx in different variants, in particular as spray, as gel or as foam formulation. Application of the composition at least temporarily reduces the snoring of a treated person. The invention further comprises the use of marrubiin for the manufacture of a medication for the treatment of snoring.
    Type: Application
    Filed: August 25, 2011
    Publication date: December 15, 2011
    Applicant: PURANOX MEDICAL B.V.
    Inventors: Hans Marcel Brand, Annelize Frieda Goedbloed
  • Publication number: 20110300198
    Abstract: The present invention relates to dermal patches comprising natural polysaccharides without the need for any pressure sensitive synthetic polymers. Particularly, the present invention relates to patches comprising a bioadhesive composition comprising a polysaccharide exudate and an essential oil useful for transdermal delivery of therapeutic or cosmetic agents.
    Type: Application
    Filed: June 3, 2011
    Publication date: December 8, 2011
    Inventors: Amos Nussinovitch, Yulia Shcherbina, Zvi Roth
  • Publication number: 20110300227
    Abstract: Methods, compositions, and strategies for the treatment of malignant neoplasms are presented herein. The treatment modalities are directed towards exploiting characteristics of cancer cells as well as correcting defective biochemical pathways and systems in the body.
    Type: Application
    Filed: May 20, 2011
    Publication date: December 8, 2011
    Applicant: NORTH TEXAS MEDICAL ASSOCIATES
    Inventor: Ivan E. Danhof